Last reviewed · How we verify
NCT04479579
Improved Adherence With Extended Venous Thromboembolism Prophylaxis After Major Cancer Surgery
Phase 4 trial testing Apixaban 2.5 milligram in Neoplasms Malignant in 53 participants. Completed in 6 November 2021.
31 October 2021
Quick facts
| Lead sponsor | McMaster University |
|---|---|
| Phase | Phase 4 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 53 |
| Start date | 22 February 2021 |
| Primary completion | 31 October 2021 |
| Estimated completion | 6 November 2021 |
| Sites | 2 locations across Canada |
Drugs / interventions tested
- Apixaban 2.5 milligram — full drug profile →
Conditions studied
- Neoplasms Malignant — all drugs for Neoplasms Malignant →
- Surgery — all drugs for Surgery →
- Venous Thromboembolism — all drugs for Venous Thromboembolism →
- Prophylaxis — all drugs for Prophylaxis →
Sponsor
McMaster University
Who can join
18 and older, any sex, with Neoplasms Malignant or Surgery. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a prospective, twin-center, cohort study in patients discharged from the hospital after major abdominal or pelvic cancer surgery for cancer. This study is designed to evaluate the adherence to extended deep vein thrombosis prophylaxis (DVT) with the direct oral anticoagulant apixaban on the background of historical data from the investigator's center on low-molecular-weight heparin (LMWH) substandard adherence in the same setting.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04479579
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Apixaban 2.5 milligram
Trials testing the same drug.
- NCT03935451 — Postoperative Extended Venous Thromboprophylaxis in Inflammatory Bowel Disease · EARLY_PHASE1 · unknown
Other recruiting trials for Neoplasms Malignant
Currently open trials in the same condition.
- NCT05939687 — Prophylactic Mesh Placement During Stoma Closure After Low Anterior Resection · Phase 3 · recruiting
Other McMaster University trials
Trials by the same sponsor.
- NCT06231069 — Mixed Exercise Training and Novel Multi-Nutrient Supplementation in Young Adults · NA · withdrawn
- NCT07213492 — Multimodal Intervention to Support Hospital-to-Community Transition in Bipolar Disorder · NA · recruiting
- NCT07486505 — Mindfulness in Fracture Recovery and Reduction of Opioid Reliance: Evaluating the Feasibility of Implementing a Brief, M · NA · not yet recruiting
- NCT07408128 — Partner4Exercise Randomized Controlled Trial · Phase 2, PHASE3 · not yet recruiting
- NCT07459777 — Early arthroscoPic Stabilization veRsus rehabilitatiOn of the Shoulder in Adolescents With a trauMatic First-time Anteri · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04479579 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by McMaster University
- Last refreshed: 22 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04479579.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing